We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$54.6B
AUM Growth
+$6.32B
Cap. Flow
+$1.41B
Cap. Flow %
2.59%
Top 10 Hldgs %
18.73%
Holding
4,080
New
257
Increased
1,843
Reduced
1,682
Closed
179
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVIA icon
3801
Zevia
ZVIA
$108M
$27K ﹤0.01%
13,539
-32,373
-71% -$64.9K
EMX
3802
DELISTED
EMX Royalty
EMX
$26K ﹤0.01%
16,019
TGB
3803
Trekor Metals
TGB
$2.56B
$26K ﹤0.01%
18,695
GNPX icon
3804
Genprex
GNPX
$3.94M
$25K ﹤0.01%
+2
New +$23.1K
AKBA icon
3805
Akebia Therapeutics
AKBA
$327M
$23K ﹤0.01%
+18,736
New +$19.1K
PYXS icon
3806
Pyxis Oncology
PYXS
$165M
$23K ﹤0.01%
12,950
RGLS
3807
DELISTED
Regulus Therapeutics
RGLS
$22K ﹤0.01%
17,500
LICY
3808
DELISTED
Li-Cycle Holdings Corp.
LICY
$22K ﹤0.01%
4,748
-5,849
-55% -$66.4K
XFOR icon
3809
X4 Pharmaceuticals
XFOR
$363M
$21K ﹤0.01%
837
-55
-6% -$1.34K
PXLW icon
3810
Pixelworks
PXLW
$38.8M
$20K ﹤0.01%
1,300
RIGL icon
3811
Rigel Pharmaceuticals
RIGL
$680M
$20K ﹤0.01%
+1,349
New +$13.8K
MJUS
3812
DELISTED
Amplify U.S. Alternative Harvest ETF
MJUS
$20K ﹤0.01%
12,322
-10,868
-47% -$17.2K
APLM icon
3813
Apollomics
APLM
$40M
$19K ﹤0.01%
+200
New +$24.6K
BLUE
3814
DELISTED
bluebird bio
BLUE
$19K ﹤0.01%
+705
New +$43K
CIF
3815
DELISTED
MFS Intermediate High Income Fund
CIF
$19K ﹤0.01%
10,854
-13,925
-56% -$22.4K
CLNN icon
3816
Clene
CLNN
$68.9M
$19K ﹤0.01%
+3,158
New +$27.5K
GEVO icon
3817
Gevo
GEVO
$397M
$19K ﹤0.01%
16,296
-2,240
-12% -$2.56K
ORGN
3818
DELISTED
Origin Materials
ORGN
$19K ﹤0.01%
754
+283
+60% +$8.11K
GWH icon
3819
ESS Tech
GWH
$22.1M
$18K ﹤0.01%
1,053
+171
+19% +$3.47K
BCDA icon
3820
BioCardia
BCDA
$12.7M
$17K ﹤0.01%
1,733
+1,060
+158% +$8.6K
CATX icon
3821
Perspective Therapeutics
CATX
$332M
$17K ﹤0.01%
4,228
DBVT
3822
DBV Technologies
DBVT
$807M
$17K ﹤0.01%
1,788
+118
+7% +$1.14K
SGMO
3823
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$17K ﹤0.01%
31,648
-18,648
-37% -$8.6K
FRZA
3824
DELISTED
Forza X1, Inc. Common Stock
FRZA
$17K ﹤0.01%
31,500
+12,500
+66% +$7.81K
AQMS icon
3825
Aqua Metals
AQMS
$9.63M
$16K ﹤0.01%
107

Similar funds

Commonwealth Equity Services's Q4 2023 Portfolio in Review

As of Q4 2023, Commonwealth Equity Services held 4,080 positions worth $54.6B, up 13% from $48.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services's Q4 2023 filing shows 257 new, 1,843 increased, 1,682 reduced and 179 closed positions. Its largest new stake was FT Vest US Equity Moderate Buffer ETF November: 440,086 shares worth $14M. The largest sale was iShares iBonds Dec 2023 Term Treasury ETF, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Commonwealth Equity Services's largest Q4 2023 buy was FT Vest US Equity Moderate Buffer ETF November: 440,086 shares worth $14M.
  • Commonwealth Equity Services added most to Invesco QQQ Trust in Q4 2023, an estimated $61.8M increase.
  • Commonwealth Equity Services's biggest Q4 2023 reduction was FT Vest US Equity Enhance & Moderate Buffer ETF December, cutting an estimated $21.8M.
  • Commonwealth Equity Services fully exited iShares iBonds Dec 2023 Term Treasury ETF in Q4 2023, selling an estimated $35.7M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $54.6B portfolio in Q4 2023.
  • Commonwealth Equity Services opened 257 new positions and closed 179 in Q4 2023.
  • Commonwealth Equity Services's portfolio value rose 13% quarter-over-quarter to $54.6B.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.